Evidence map›Paper›PMID 39716635›Full record

ArticleOphthalmology2025

Accelerated Epigenetic Aging Is Associated with Faster Glaucoma Progression: A DNA Methylation Study.

Felipe A Medeiros, Achintya Varma, Alessandro A Jammal, Henry Tseng, William K Scott

Abstract read
In one paragraph

Article in Ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Felipe A MedeirosBascom Palmer Eye Institute, University of Miami, Miami, Florida; Duke Eye Center and Department of Ophthalmology, Duke University, Durham, North Carolina. Electronic address: fmedeiros@med.miami.edu.
Achintya VarmaJohn P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida.
Alessandro A JammalBascom Palmer Eye Institute, University of Miami, Miami, Florida.
Henry TsengDuke Eye Center and Department of Ophthalmology, Duke University, Durham, North Carolina.
William K ScottJohn P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida; Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida.

Funding

The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in GlaucomaR01EY029885 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MEDEIROS, FELIPE · 2019 to 2022
$2.2M
NEI NIH HHS R01 EY029885
6 · The paper itself

Abstract

purposeTo investigate the association between epigenetic age acceleration and glaucoma progression.

designRetrospective cohort study.

participantsA total of 100 patients with primary open-angle glaucoma (POAG) with fast progression and 100 patients with POAG with slow progression.

methodsPatients were classified as fast or slow progressors based on rates of change in standard automated perimetry (SAP) mean deviation (MD) and retinal nerve fiber layer (RNFL) thickness. Epigenetic age was calculated using the Horvath, Hannum, PhenoAge, and GrimAge clocks from DNA methylation profiles obtained from blood samples. Age acceleration was defined as the residual from a linear regression of epigenetic age on chronologic age, with positive values suggesting faster biological aging. Multivariable logistic regression models estimated the association between age acceleration and likelihood of fast progression, adjusting for confounders.

main outcome measuresDifference in epigenetic age acceleration between fast and slow glaucoma progressors.

resultsThe mean rate of SAP MD change in the fastest progressing eye was -1.06 dB/year (95% confidence interval [CI], -1.28 to -0.85 dB/year) for fast progressors compared with -0.10 dB/year (95% CI, -0.16 to -0.04 dB/year) for slow progressors (P < 0.001). For RNFL thickness, corresponding values were -1.60 μm/year (95% CI, -1.97 to -1.23 μm/year) and -0.76 μm/year (95% CI, -1.04 to -0.48 μm/year), respectively (P < 0.001). Fast progressors demonstrated significantly greater age acceleration compared with slow progressors for the Horvath clock (mean difference, 2.93 years; 95% CI, 1.48-4.39 years; P < 0.001) and Hannum clock (mean difference, 1.24 years; 95% CI, 0.03-2.46 years; P = 0.045). In multivariable models, each year of Horvath age acceleration was associated with 15% higher odds of fast progression (odds ratio, 1.15; 95% CI, 1.07-1.23; P < 0.001). Hannum and GrimAge clocks also showed significant associations with fast progression. The association between age acceleration and fast progression was stronger in those with relatively low IOP during follow-up.

conclusionsAccelerated epigenetic aging was associated with faster glaucoma progression. These findings suggest that faster biological age, as reflected in DNA methylation, may increase optic nerve susceptibility to damage, highlighting epigenetic age as a potential prognostic biomarker. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

AgingDNA MethylationEpigenesis, GeneticGlaucoma, Open-AngleAgedDisease ProgressionFemaleHumansIntraocular PressureMaleMiddle AgedNerve FibersRetinal Ganglion CellsRetrospective StudiesVisual FieldsVisual Field TestsAgingEpigeneticsGlaucomaGlaucoma progressionMethylation

Identifiers

PMID39716635
PMCPMC12307055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.